Clinical Trial Results:
A Single Dose, Randomized, 2-Period Crossover Study in Patients with Hemophilia A to Evaluate the Pharmacokinetics of Refacto(B-domain deleted recombinant human factor VIII (BDDrFVIII) and Advate (a full-length recombinant factor VIII (FLrFVIII)
Summary
|
|
EudraCT number |
2004-003727-12 |
Trial protocol |
DE GB IT |
Global completion date |
10 May 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 Jan 2019
|
First version publication date |
25 Jan 2019
|
Other versions |
|
Summary report(s) |
3082A-101711_cancelled study |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.